Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV NAC for TB Drug-Induced Hepatitis
NCT02182167Phase 3Completed
- Sponsor
- University of Cape Town
- Start
- May 2014
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in drug induced liver injury (DILI), sponsored by University of Cape Town. Started May 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
drug induced liver injury (DILI)
Beyond the preview
Go deeper on NCT02182167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182167.